PRNB - Principia Biopharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Principia Biopharma's activity chart (see below) currently has 30 price targets and 25 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 92.14% of the time, taking 114 days on average.

Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 20-Aug-2020. First documented stock forecast 09-Oct-2018.

Best performing analysts who are covering PRNB - Principia Biopharma:

Joseph Pantginis Derek Archila Brian Skorney Tazeen Ahmad Geoffrey Porges

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Apr-2019

$76

6 years 3 months 2 days ago
(20-Aug-2020)

5/5 (100%)

$22.11 (41.03%)

110

Buy Since 09-Oct-2018

$100

$112

6 years 3 months 4 days ago
(18-Aug-2020)

3/4 (75%)

$0.39 (0.39%)

137

Buy Since 09-Oct-2018

$100

$78

6 years 3 months 4 days ago
(18-Aug-2020)

3/3 (100%)

$0.39 (0.39%)

174

Buy Since 01-Jul-2019

$108

6 years 3 months 5 days ago
(17-Aug-2020)

6/7 (85.71%)

$16.11 (17.53%)

72

Buy Since 09-Oct-2018

$68

$33

6 years 9 months 30 days ago
(23-Jan-2020)

2/2 (100%)

$7.8 (12.96%)

77

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRNB (Principia Biopharma) average time for price targets to be met?

On average it took 114 days for the stock forecasts to be reached, with an average price target met ratio of 92.14%.

Which analyst most recently updated their price target on PRNB (Principia Biopharma)?

Derek Archila

Which analyst has the lowest performance score on PRNB (Principia Biopharma) with a proven track record?

GEOFFREY PORGES

Which analyst has the most public recommendations on PRNB (Principia Biopharma)?

Derek Archila works at WELLS FARGO and has 2 price targets and 3 ratings on PRNB

Which analyst is the currently most bullish on PRNB (Principia Biopharma)?

Derek Archila with the highest potential upside of $0

Which analyst is the currently most reserved on PRNB (Principia Biopharma)?

Tazeen Ahmad with the lowest potential downside of -$32.05
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?